LSE · AZN.L
AstraZeneca PLC
£139.60+£9.08 (+6.96%)
AstraZeneca PLC’s quoted price sits in the upper half of its reported 52-week range, 11.26% below the high.
Loading market information…
CNQ · POKO.CN · CAD
Stock price
Quote as of Jul 12, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Poko Innovations Inc. operates at the intersection of the CBD and financial technology industries. Under its Poko brand, the company supplies skincare formulations specifically designed for various dermatological needs, including blemish-prone, aging, and dry skin types. Its fintech arm, Lumipay, provides a specialized payment gateway service exclusively for the CBD sector. Beyond these, Poko maintains a diverse digital presence. This includes Candid Magazine, a B2C publication covering lifestyle, culture, celebrity CBD news, and events; CBD Village, an e-commerce and review platform offering a wide array of CBD products from numerous brands; and The Extract, an online news and media space tailored for business-to-business audiences. Poko also markets its own line of Canndid CBD products. Furthermore, it oversees Cannmed, which encompasses both a marketplace for wholesale premium white-labeling and raw materials (referred to as Cannmed products) and a distinct general Cannmed Marketplace. The company is based in London, United Kingdom.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:58 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£139.60+£9.08 (+6.96%)
AstraZeneca PLC’s quoted price sits in the upper half of its reported 52-week range, 11.26% below the high.
$0.08$0.00 (0.0%)
SpotLite360 IOT Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 21.84% below the high.
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
CA$0.05CA$0.00 (0.0%)
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.88% below the high.
CA$0.04CA$0.00 (0.0%)
Canada House Cannabis Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
CA$0.01CA$0.00 (0.0%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.00$0.00 (0.0%)
West Island Brands Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Fiore Cannabis Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
